Damnacanthal inhibits IgE receptor-mediated activation of mast cells

Molecular Immunology

Volumn 65, Issue 1, 2015, Pages 86-93

  Garcia Vilas, Javier A ^a,b   Medina, Miguel A ^a,b   Melo, Fabio R ^c   Pejler, Gunnar ^c,d   Garcia Faroldi, Gianni ^c  

^a UNIVERSITY OF MÁLAGA   (Spain)

^b CENTRO DE INVESTIGACIÓN BIOMÉDICA EN RED DE ENFERMEDADES RARAS CIBERER   (Spain)

^c SWEDISH UNIVERSITY OF AGRICULTURAL SCIENCES   (Sweden)

^d UPPSALA UNIVERSITY   (Sweden)

Author keywords

Activation; Cytokines; Damnacanthal; Degranulation; IgE R cross linking; Mast cell

Indexed keywords

BETA N ACETYLHEXOSAMINIDASE; CALCIMYCIN; DAMNACANTHAL; FC RECEPTOR; FC RECEPTOR I; IMMUNOGLOBULIN E RECEPTOR; PROTEIN KINASE B; PROTEIN KINASE SYK; TRYPTASE; UNCLASSIFIED DRUG; ANTHRAQUINONE DERIVATIVE; ANTIINFLAMMATORY AGENT; CYTOKINE; PROTEIN TYROSINE KINASE; SIGNAL PEPTIDE;

ANIMAL CELL; ANTIINFLAMMATORY ACTIVITY; ARTICLE; BONE MARROW DERIVED MAST CELL; CELL VIABILITY; CONCENTRATION RESPONSE; CONTROLLED STUDY; CROSS LINKING; CYTOKINE RELEASE; CYTOTOXICITY; ENZYME RELEASE; GENE INDUCTION; MAST CELL; MAST CELL DEGRANULATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; UPREGULATION; WESTERN BLOTTING; ANIMAL; ANTAGONISTS AND INHIBITORS; BONE MARROW CELL; C57BL MOUSE; DEGRANULATION; DRUG EFFECTS; IMMUNOLOGY; INFLAMMATION; METABOLISM; PHOSPHORYLATION; SECRETION (PROCESS);

MORINDA CITRIFOLIA;

ANIMALS; ANTHRAQUINONES; ANTI-INFLAMMATORY AGENTS; BETA-N-ACETYLHEXOSAMINIDASES; BONE MARROW CELLS; CALCIMYCIN; CELL DEGRANULATION; CYTOKINES; INFLAMMATION; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; MAST CELLS; MICE; MICE, INBRED C57BL; PHOSPHORYLATION; PROTEIN-TYROSINE KINASES; PROTO-ONCOGENE PROTEINS C-AKT; RECEPTORS, IGE; TRYPTASES;

EID: 84921954788     PISSN: 01615890     EISSN: 18729142     Source Type: Journal    
DOI: 10.1016/j.molimm.2015.01.008     Document Type: Article

References (28)

1. Alitheen N.B., Mashitoh A.R., Yeap S.K., Shuhaimi M., Manaf A.A., Nordin L. Cytotoxic effect of damnacanthal, nordamnacanthal, zerumbone and betulinic acid isolated from Malaysian plant sources. Int. Food Res. J. 2010, 17:711-719.
2. Brown A.C. Anticancer activity of Morinda citrifolia (Noni) fruit: a review. Phytother. Res. 2012, 26:1427-1440.
3. Cho S.H., Woo C.H., Yoon S.B., Kim J.H. Protein kinase Cdelta functions downstream of Ca2+ mobilization in FcepsilonRI signaling to degranulation in mast cells. J. Allergy Clin. Immunol. 2004, 114:1085-1092.
4. Faltynek C.R., Schroeder J., Mauvais P., Miller D., Wang S., Murphy D., Lehr R., Kelley M., Maycock A., Michne W., et al. Damnacanthal is a highly potent, selective inhibitor of p56lck tyrosine kinase activity. Biochemistry 1995, 34:12404-12410.
5. Galli S.J., Grimbaldeston M., Tsai M. Immunomodulatory mast cells: negative, as well as positive, regulators of immunity. Nat. Rev. Immunol. 2008, 8:478-486.
6. Galli S.J., Nakae S., Tsai M. Mast cells in the development of adaptive immune responses. Nat. Immunol. 2005, 6:135-142.
7. Garcia-Faroldi G., Melo F.R., Bruemmer D., Conneely O.M., Pejler G., Lundequist A. Nuclear receptor 4a3 (nr4a3) regulates murine mast cell responses and granule content. PLOS ONE 2014, 9:e89311.
8. Garcia-Faroldi G., Ronnberg E., Orro A., Calounova G., Guss B., Lundequist A., Pejler G. ADAMTS: novel proteases expressed by activated mast cells. Biol. Chem. 2013, 394:291-305.
9. Gilfillan A.M., Rivera J. The tyrosine kinase network regulating mast cell activation. Immunol. Rev. 2009, 228:149-169.
10. He Y., Luo Y., Tang S., Rajantie I., Salven P., Heil M., Zhang R., Luo D., Li X., Chi H., et al. Critical function of Bmx/Etk in ischemia-mediated arteriogenesis and angiogenesis. J. Clin. Invest. 2006, 116:2344-2355.
11. Henningsson F., Ledin J., Lunderius C., Wilen M., Hellman L., Pejler G. Altered storage of proteases in mast cells from mice lacking heparin: a possible role for heparin in carboxypeptidase A processing. Biol. Chem. 2002, 383:793-801.
12. Inngjerdingen M., Torgersen K.M., Maghazachi A.A. Lck is required for stromal cell-derived factor 1 alpha (CXCL12)-induced lymphoid cell chemotaxis. Blood 2002, 99:4318-4325.
13. Kanokmedhakul K., Kanokmedhakul S., Phatchana R. Biological activity of anthraquinones and triterpenoids from Prismatomeris fragrans. J. Ethnopharmacol. 2005, 100:284-288.
14. Kitaura J., Asai K., Maeda-Yamamoto M., Kawakami Y., Kikkawa U., Kawakami T. Akt-dependent cytokine production in mast cells. J. Exp. Med. 2000, 192:729-740.
15. Law C.L., Chandran K.A., Sidorenko S.P., Clark E.A. Phospholipase C-gamma1 interacts with conserved phosphotyrosyl residues in the linker region of Syk and is a substrate for Syk. Mol. Cell. Biol. 1996, 16:1305-1315.
16. Lundequist A., Calounova G., Wensman H., Ronnberg E., Pejler G. Differential regulation of Nr4a subfamily nuclear receptors following mast cell activation. Mol. Immunol. 2011, 48:1753-1761.
17. Metcalfe D.D., Baram D., Mekori Y.A. Mast cells. Physiol. Rev. 1997, 77:1033-1079.
18. Nualsanit T., Rojanapanthu P., Gritsanapan W., Kwankitpraniti T., Min K.W., Baek S.J. Damnacanthal-induced anti-inflammation is associated with inhibition of NF-kappaB activity. Inflamm. Allergy Drug Targets 2011, 10:455-463.
19. Pawlus A.D., Kinghorn D.A. Review of the ethnobotany, chemistry, biological activity and safety of the botanical dietary supplement Morinda citrifolia (noni). J. Pharm. Pharmacol. 2007, 59:1587-1609.
20. Potterat O., Hamburger M. Morinda citrifolia (Noni) fruit - phytochemistry, pharmacology, safety. Planta Med. 2007, 73:191-199.
21. Razin E., Cordon-Cardo C., Good R.A. Growth of a pure population of mouse mast cells in vitro with conditioned medium derived from concanavalin A-stimulated splenocytes. Proc. Natl. Acad. Sci. U. S. A. 1981, 78:2559-2561.
22. Rivera J., Fierro N.A., Olivera A., Suzuki R. New insights on mast cell activation via the high affinity receptor for IgE. Adv. Immunol. 2008, 98:85-120.
23. Rivera J., Gilfillan A.M. Molecular regulation of mast cell activation. J. Allergy Clin. Immunol. 2006, 117:1214-1225. (quiz 1226).
24. Saha K., Lam K.W., Abas F., Hamzah A.S., Stanslas J., Hui L.S., Lajis N.H. Synthesis of damnacanthal, a naturally occurring 9,10-anthraquinone and its analogues, and its biological evaluation against five cancer cell lines. Med. Chem. Res. 2013, 22:2093-2104.
25. Theoharides T.C., Alysandratos K.D., Angelidou A., Delivanis D.A., Sismanopoulos N., Zhang B., Asadi S., Vasiadi M., Weng Z., Miniati A., Kalogeromitros D. Mast cells and inflammation. Biochim. Biophys. Acta 2012, 1822:21-33.
26. Wang M.Y., West B.J., Jensen C.J., Nowicki D., Su C., Palu A.K., Anderson G. Morinda citrifolia (Noni): a literature review and recent advances in Noni research. Acta Pharmacol. Sin. 2002, 23:1127-1141.
27. Wernersson S., Pejler G. Mast cell secretory granules: armed for battle. Nat. Rev. Immunol. 2014, 14:478-494.
28. Yu M., Tsai M., Tam S.Y., Jones C., Zehnder J., Galli S.J. Mast cells can promote the development of multiple features of chronic asthma in mice. J. Clin. Invest. 2006, 116:1633-1641.